Sarpel U, Hefti M M, Wisnievsky J P, Roayaie S, Schwartz M E, Labow D M
Department of Surgery, New York University Medical Center, New York, USA.
Ann Surg Oncol. 2009 Jun;16(6):1572-7. doi: 10.1245/s10434-009-0414-8. Epub 2009 Mar 4.
This is a case-matched analysis of patients undergoing laparoscopic versus open hepatectomy for hepatocellular carcinoma (HCC), with specific regard to margin status and survival.
Laparoscopic cases were matched with open controls by cirrhosis and tumor size (within 10%). Data were evaluated by logistic regression using the generalized estimating equation method. Mixed linear regression models were used to assess operative duration in the groups. Overall and disease-free survival were compared using a Cox proportional frailty model.
Twenty laparoscopic cases were matched to 56 open resections. Thirty patients (39%) developed recurrence and 13 patients (17%) died, including one (1.3%) death within 30 days. There were no significant differences in age, gender, cirrhosis or tumor size. Paired univariate and multivariate analyses showed cases of laparoscopic resection had similar rates of transfusion and positive margins compared with open resection. Operative duration was similar in laparoscopic (mean 161 +/- 37 min) and open (mean 165 +/- 53 min) groups. The adjusted odds of length of stay > or = 6 days was significantly lower in patients with laparoscopic resection [odds ratio (OR) = 0.07, 95% confidence interval (CI) = 0.02-0.27]. Both unadjusted and adjusted analyses showed no significant association between type of resection and overall or disease-free survival.
Neither margin status, nor recurrence, nor survival was significantly different between the two cohorts. Laparoscopic resection for malignancy is safe, with a similar operative time as open hepatectomy. If tumor location is amenable, laparoscopic resection for HCC is a reasonable alternative to open resection with the added benefits of improved cosmesis and sooner discharge home.
这是一项针对接受腹腔镜与开腹肝切除术治疗肝细胞癌(HCC)患者的病例匹配分析,特别关注切缘状态和生存率。
通过肝硬化和肿瘤大小(相差10%以内)将腹腔镜手术病例与开腹手术对照进行匹配。数据采用广义估计方程法通过逻辑回归进行评估。使用混合线性回归模型评估各组的手术时长。采用Cox比例脆弱模型比较总生存期和无病生存期。
20例腹腔镜手术病例与56例开腹切除术病例相匹配。30例患者(39%)出现复发,13例患者(17%)死亡,包括1例(1.3%)在30天内死亡。年龄、性别、肝硬化或肿瘤大小方面无显著差异。配对单因素和多因素分析显示,与开腹切除术相比,腹腔镜切除术病例的输血率和切缘阳性率相似。腹腔镜组(平均161±37分钟)和开腹组(平均165±53分钟)的手术时长相似。腹腔镜切除术患者住院时间≥6天的校正比值显著更低[比值比(OR)=0.07,95%置信区间(CI)=0.02 - 0.27]。未校正和校正分析均显示,手术切除类型与总生存期或无病生存期之间无显著关联。
两组在切缘状态、复发率或生存率方面均无显著差异。恶性肿瘤的腹腔镜切除术是安全的,手术时间与开腹肝切除术相似。如果肿瘤位置合适,对于HCC患者,腹腔镜切除术是开腹切除术的合理替代方案,具有改善美观和更快出院的额外益处。